Cargando…

Neuroprotective Activity of Peripherally Administered Liver Growth Factor in a Rat Model of Parkinson’s Disease

Liver growth factor (LGF) is a hepatic mitogen purified some years ago that promotes proliferation of different cell types and the regeneration of damaged tissues, including brain tissue. Considering the possibility that LGF could be used as a therapeutic agent in Parkinson’s disease, we analyzed it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalo-Gobernado, Rafael, Calatrava-Ferreras, Lucía, Reimers, Diana, Herranz, Antonio Sánchez, Rodríguez-Serrano, Macarena, Miranda, Cristina, Jiménez-Escrig, Adriano, Díaz-Gil, Juan José, Bazán, Eulalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701531/ https://www.ncbi.nlm.nih.gov/pubmed/23861803 http://dx.doi.org/10.1371/journal.pone.0067771

Ejemplares similares

Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2020)

Neuroprotective Role of Liver Growth Factor “LGF” in an Experimental Model of Cerebellar Ataxia
por: Calatrava-Ferreras, Lucía, et al.
Publicado: (2014)

Liver Growth Factor as a Tissue Regenerating Factor in Neurodegenerative Diseases
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2014)

Effects of Intravenous Administration of Human Umbilical Cord Blood Stem Cells in 3-Acetylpyridine-Lesioned Rats
por: Calatrava-Ferreras, Lucía, et al.
Publicado: (2012)

Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich’s Ataxia Transgenic Mice
por: Calatrava-Ferreras, Lucía, et al.
Publicado: (2016)

Immunohistochemical Study of ASC Expression and Distribution in the Hippocampus of an Aged Murine Model of Alzheimer’s Disease
por: Reimers, Diana, et al.
Publicado: (2021)

Liver Growth Factor “LGF” as a Therapeutic Agent for Alzheimer’s Disease
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2020)

Optimal excitation and emission wavelengths to analyze amino acids and optimize neurotransmitters quantification using precolumn OPA-derivatization by HPLC
por: Perucho, J., et al.
Publicado: (2015)

Repetitive Immunization Enhances the Susceptibility of Mice to Peripherally Administered Prions
por: Bremer, Juliane, et al.
Publicado: (2009)

Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
por: Poirier, Andrée-Anne, et al.
Publicado: (2022)

Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2023)

Neuroprotective Effects of Diets Containing Olive Oil and DHA/EPA in a Mouse Model of Cerebral Ischemia
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2019)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Workplace violence against healthcare workers: an observational study in Castilla y León (Spain)
por: López-Gobernado, Miguel, et al.
Publicado: (2020)

Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson’s disease
por: Srivastava, Pranay, et al.
Publicado: (2023)

The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants
por: Li, Weimin, et al.
Publicado: (2023)

Medical Management of Parkinson’s Disease: Focus on Neuroprotection
por: Boll, Marie-Catherine, et al.
Publicado: (2011)

Neuroprotection by Nrf2 in Parkinson’s disease model
Publicado: (2011)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

Neuroprotective Function of DJ-1 in Parkinson's Disease
por: Ariga, Hiroyoshi, et al.
Publicado: (2013)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Valproate Administered after Traumatic Brain Injury Provides Neuroprotection and Improves Cognitive Function in Rats
por: Dash, Pramod K., et al.
Publicado: (2010)

Neuroprotective effect of dexmedetomidine on autophagy in mice administered intracerebroventricular injections of Aβ(25–35)
por: Lee, Youn Young, et al.
Publicado: (2023)

Peripherally administered orexin improves survival of mice with endotoxin shock
por: Ogawa, Yasuhiro, et al.
Publicado: (2016)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
por: Lauterbach, Edward C., et al.
Publicado: (2012)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Neuroprotective potential of Beta vulgaris L. in Parkinson's disease
por: Nade, Vandana S., et al.
Publicado: (2015)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
por: Grimmig, Beth, et al.
Publicado: (2017)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
por: Sheng, Xiaoyan, et al.
Publicado: (2021)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)

Prolonged Peripheral Hypoperfusion Promotes Neuroprotection in Ischemic Stroke
por: Heiberger, Caleb J, et al.
Publicado: (2019)

Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy
por: Alarcon-Gil, Jesus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4omo0849d61h9rj1oomsbo5d7c